Matinas BioPharma
MTNB
MTNB
39 hedge funds and large institutions have $3.66M invested in Matinas BioPharma in 2018 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 7 increasing their positions, 14 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
39
Holders Change
-6
Holders Change %
-13.33%
% of All Funds
0.89%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
7
Reduced
14
Closed
19
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
Goldman Sachs
New York
|
+$204K |
2 |
ECM
Element Capital Management
New York
|
+$171K |
3 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$130K |
4 |
IA
IFP Advisors
Tampa,
Florida
|
+$130K |
5 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
+$107K |
Top Sellers
1 |
BlackRock
New York
|
-$1.04M |
2 |
State Street
Boston,
Massachusetts
|
-$366K |
3 |
AWMG
Alliance Wealth Management Group
Flemington,
New Jersey
|
-$307K |
4 |
Northern Trust
Chicago,
Illinois
|
-$219K |
5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$145K |